Date updated:10-16-2007
This fund has a Morningstar rating of 3 stars and is run by Andrew Oh. Oh is manager of Pharmaceuticals Portfolio, which he has managed since July 2006. He joined Fidelity Investments in 2006 as an equity research analyst. Prior to Fidelity, Oh was director and senior pharmaceuticals analyst for Leernik Swann & Company in New York. From 2001 to 2004, he was senior equity research associate following the U.S. large cap pharmaceuticals sector for JP Morgan Chase in New York. Fidelity Select Pharmaceuticals Portfolio is an open-end fund incorporated in the USA. The Fund's objective is capital appreciation. The Fund normally invests at least 80% of assets in companies engaged in the research, development, manufacture, sale, or distribution of pharmaceuticals and drugs of all types.
Current Returns:
1-Year: 13.69%
3-Year: 16.64%
5-Year: 12.12%

-
MRK
Merck Co Inc - $32.59
- -0.37%
- $32.61
No Analysis added

-
SGP
Sgp - $0.00
- N/A
- $N/A
No Analysis added

-
BMY
Bristol-myers Squ - $22.64
- +0.62%
- $22.56
No Analysis added

-
WYE
Wye - $0.00
- N/A
- $N/A
No Analysis added

-
ABT
Abbott Laboratori - $51.53
- -0.17%
- $51.45
No Analysis added

-
JNJ
Johnson And Johns - $60.30
- +0.53%
- $59.94
No Analysis added

-
LLY
Lilly Eli Co - $34.50
- +0.20%
- $34.39
No Analysis added

-
PFE
Pfizer Inc - $16.96
- -0.35%
- $17.01
No Analysis added
- Top Professional Portfolios
- 1. Navellier & Associ...
- 2. Fidelity Contrafund - ...
- 3. Argus Management
- 4. WisdomTree Intl Consum...
- 5. Charlie Munger
- show all
- Top Do-It-Yourself Portfolios
- » John Shier
- » Joy
- » tsamanuli Portfolio 1
- » brueckenc Portfolio 1
- » Fundsonly Portfolio 1
- show all
- Most Viewed Portfolios
- » Warren Buffett
- » George Soros
- » T. Boone Pickens - BP Cap...
- » Carl Icahn
- » Renaissance Technologies
- show all
By Roberto Pedone Posted on Nov. 6, 2009 According to Jim Cramer, the bears are tellinginvestors six lies. On Wednesday’s “Mad Money” TV show, Cramer said if you ...
By Roberto Pedone Posted on Nov. 5, 2009 The traders on CNBC’s “Fast Money” told their viewers what they must know after Warren Buffett announced on Tuesday his l...
By Jonas Elmerraji Posted on Nov. 4, 2009 For investors who seek out short-squeeze opportunities, there’s no time as important as earnings season. Earnings are one of...
By Stockpickr Staff Posted on Nov. 4, 2009 Regardless of why a stock is in the news, it never hurts to hear what a professional investor has to say about it. The key is...
A. Won't matter . . . the damage, by in
large, has already been done . . . and
the government is on a current path to
accelerate the day of reckoning . . .
which can be quite profitable for some .
. . quite painful for others.
A. The only one I own : SLX,
too hard pick a winner out all of them
Here is the stock list of some of the largest % losers from Nov. 2, 2009. more
Here is a list of some of the biggest stocks that hit 52-week lows on Nov. 2, 2009. more
Unusually active options can often indicate that a major event in a stock is about to take place, or that unsophisticated investors (using options in lieu of leverage) are ... more













Comments not available